Education
About Us
Working with TipRanks
Follow Us
Australian Clinical Labs Ltd (AU:ACL)
ASX:ACL
RESEARCH TOOLSreports
Earnings Data
Report Date
Feb 24, 2026TBA (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.07Last Year’s EPS
0.06Same Quarter Last Year
Strong Buy
Based on 6 Analysts Ratings
AU:ACL Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
AU:ACL Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 25, 2025 | AU$2.42 | AU$2.58 | +6.61% |
Feb 25, 2025 | AU$3.54 | AU$3.13 | -11.58% |
Aug 28, 2024 | AU$2.48 | AU$2.71 | +9.27% |
Feb 27, 2024 | AU$2.40 | AU$2.24 | -6.67% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Australian Clinical Labs Ltd (AU:ACL) report earnings?
Australian Clinical Labs Ltd (AU:ACL) is schdueled to report earning on Feb 24, 2026, TBA (Confirmed).
What is Australian Clinical Labs Ltd (AU:ACL) earnings time?
Australian Clinical Labs Ltd (AU:ACL) earnings time is at Feb 24, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Australian Clinical Labs Ltd stock?
The P/E ratio of Australian Clinical Labs Ltd is N/A.
What is AU:ACL EPS forecast?
AU:ACL EPS forecast for the fiscal quarter 2026 (Q2) is 0.07.